4-3074876-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2
The NM_001388492.1(HTT):c.81_110dupGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA(p.Gln28_Gln37dup) variant causes a disruptive inframe insertion change. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0040 ( 5 hom., cov: 0)
Exomes 𝑓: 0.0015 ( 19 hom. )
Failed GnomAD Quality Control
Consequence
HTT
NM_001388492.1 disruptive_inframe_insertion
NM_001388492.1 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.84
Publications
6 publications found
Genes affected
HTT (HGNC:4851): (huntingtin) Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016]
HTT Gene-Disease associations (from GenCC):
- Huntington diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- Lopes-Maciel-Rodan syndromeInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- juvenile Huntington diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_001388492.1
BP6
Variant 4-3074876-C-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG is Benign according to our data. Variant chr4-3074876-C-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG is described in ClinVar as [Likely_benign]. Clinvar id is 2654593.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00405 (534/131868) while in subpopulation AMR AF = 0.00619 (83/13410). AF 95% confidence interval is 0.00511. There are 5 homozygotes in GnomAd4. There are 223 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR,AD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HTT | NM_001388492.1 | c.81_110dupGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA | p.Gln28_Gln37dup | disruptive_inframe_insertion | Exon 1 of 67 | ENST00000355072.11 | NP_001375421.1 | |
HTT | NM_002111.8 | c.81_110dupGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA | p.Gln28_Gln37dup | disruptive_inframe_insertion | Exon 1 of 67 | NP_002102.4 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00404 AC: 533AN: 131770Hom.: 5 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
533
AN:
131770
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00150 AC: 1834AN: 1225782Hom.: 19 Cov.: 0 AF XY: 0.00160 AC XY: 976AN XY: 608110 show subpopulations
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1834
AN:
1225782
Hom.:
Cov.:
0
AF XY:
AC XY:
976
AN XY:
608110
show subpopulations
African (AFR)
AF:
AC:
34
AN:
25812
American (AMR)
AF:
AC:
100
AN:
30296
Ashkenazi Jewish (ASJ)
AF:
AC:
42
AN:
22736
East Asian (EAS)
AF:
AC:
43
AN:
29096
South Asian (SAS)
AF:
AC:
139
AN:
72228
European-Finnish (FIN)
AF:
AC:
70
AN:
32494
Middle Eastern (MID)
AF:
AC:
7
AN:
3784
European-Non Finnish (NFE)
AF:
AC:
1310
AN:
957500
Other (OTH)
AF:
AC:
89
AN:
51836
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
48
96
143
191
239
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00405 AC: 534AN: 131868Hom.: 5 Cov.: 0 AF XY: 0.00352 AC XY: 223AN XY: 63418 show subpopulations
GnomAD4 genome
AF:
AC:
534
AN:
131868
Hom.:
Cov.:
0
AF XY:
AC XY:
223
AN XY:
63418
show subpopulations
African (AFR)
AF:
AC:
111
AN:
35514
American (AMR)
AF:
AC:
83
AN:
13410
Ashkenazi Jewish (ASJ)
AF:
AC:
10
AN:
3190
East Asian (EAS)
AF:
AC:
5
AN:
4124
South Asian (SAS)
AF:
AC:
6
AN:
3910
European-Finnish (FIN)
AF:
AC:
11
AN:
7368
Middle Eastern (MID)
AF:
AC:
0
AN:
252
European-Non Finnish (NFE)
AF:
AC:
299
AN:
61484
Other (OTH)
AF:
AC:
9
AN:
1816
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.546
Heterozygous variant carriers
0
22
44
65
87
109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Dec 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
HTT: BS2 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.